![Jim Fenton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jim Fenton
Investor Relations Contact bij Association for Accessible Medicines
Actieve functies van Jim Fenton
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Association for Accessible Medicines
![]() Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Investor Relations Contact | - | - |
Loopbaan van Jim Fenton
Opleiding van Jim Fenton
Georgetown University | Undergraduate Degree |
University of Oregon | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Operationeel
Undergraduate Degree | 2 |
Investor Relations Contact | 1 |
Sectoraal
Consumer Services | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Association for Accessible Medicines
![]() Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |
- Beurs
- Insiders
- Jim Fenton
- Ervaring